Brief introduction of Hongjitang Company

Hongjitang Company profile is as follows:

Hongjitang was established in 1907 and is one of the key Chinese medicine enterprises in China. It has a history of 100 years and is famous for producing Chinese patent medicines at home and abroad. 1995 was named "China's Time-honored Brand" by the Ministry of Internal Trade of People's Republic of China (PRC), 1996 was named as one of the top 50 Chinese medicine manufacturers by the Administration of Traditional Chinese Medicine, and 199 1 was recognized as a high-tech enterprise by the Shandong Provincial Science and Technology Commission.

Jinan Hongjitang Pharmaceutical Co., Ltd. covers an area of 60,000 square meters, with 923 employees, and various professional and technical personnel account for 35% of the total employees. It mainly produces 65,438+065,438+0 dosage forms and 65,438+065,438+08 varieties of capsules, oral liquids and tablets, and has more than 600 sets of various pharmaceutical equipment. Hongjitang Pharmaceutical Co., Ltd. 18. It has built the largest raw material base of montmorillonite in China, and has a Chinese medicine wisdom pharmacy and a decoction piece factory. It has become the first manufacturer of formula granules with more than 300 varieties registered in Shandong Food and Drug Administration, and its products sell well all over the world.

Brand development of Hongjitang Company

Jinan Hongjitang Pharmaceutical Co., Ltd. has a perfect marketing network covering all areas of China except Tibet and Taiwan Province Province. The international market radiates to Southeast Asia, the United States, Russia, the European Community and other countries and regions. At the same time, Hongjitang Company actively set foot in retail pharmacies, with chain pharmacies 10, and passed the national GSP certification at one time in China.

Through brand advantages, product quality advantages, market network advantages, service advantages and innovative market development advantages, the rapid growth and healthy and sustainable development of market share have been realized. In 2005, the newly listed "Fengshateng" for treating rheumatism and "Xinbaokang" for treating cardiovascular and cerebrovascular diseases quickly occupied the market with their strong market network and unique curative effect.

Jinan Hongjitang Pharmaceutical Co., Ltd. is fully implementing the development strategy of brand, scale and benefit with the modern concept of "innovation, change and Excellence", and is striving for the goal of specialization, modernization and internationalization of traditional Chinese medicine.

Reference to the above content: Baidu Encyclopedia-Shandong Hongjitang Pharmaceutical Group Co., Ltd.